Skip to main content

David F. Penson, M.D., M.P.H.

  • Chair, Department of Urologic Surgery
  • Paul V. Hamilton, MD and Virginia E. Howd Professor of Urologic Oncology
  • Co-Leader, Cancer Health Outcomes and Control Research Program
  • Director, Center for Surgical Quality and Outcomes Research

Phone

615-343-1529

Email

david.penson@Vanderbilt.Edu
Vanderbilt University Medical Center
2525 West End Avenue, Suite 1200
Nashville, TN 37203-1738

David F. Penson, M.D., M.P.H.

  • Chair, Department of Urologic Surgery
  • Paul V. Hamilton, MD and Virginia E. Howd Professor of Urologic Oncology
  • Co-Leader, Cancer Health Outcomes and Control Research Program
  • Director, Center for Surgical Quality and Outcomes Research

615-343-1529

david.penson@Vanderbilt.Edu

Vanderbilt University Medical Center
2525 West End Avenue, Suite 1200
Nashville, TN 37203-1738

Departments/Affiliations

Provider Information

Profile

Dr. Penson is a board-certified urologic oncologist who focuses on urological malignancies, particularly bladder and prostate cancer. He is an internationally recognized expert in the care of both of these common cancers and is also a federally funded researcher with a focus on patient-reported outcomes, survivorship and comparative effectiveness in prostate cancer. He serves as the American Urologic Association National Chair for Healthcare Policy and is the organization's representative to the Commission on Cancer.

Education

  • M.D. - Boston University, 1991
  • M.P.H. - Yale University, 2000

Postgraduate Training

  • General Surgery Internship -UCLA Health System, 1992
  • General Surgery Residency - UCLA Health System, 1993
  • Urology Residency - UCLA Health System, 1997
  • Fellowship - Yale University School of Medicine, 1999

Research Emphasis

Research Description

Publications

Have any questions? Contact Us 1-877-936-8422 for more information